| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
LarotRectiniB (LOXO-101) is an ATP competitive, oral selective inhibitor, three subtypes (TRKA, B and C) of the original maternal condensation kinase (TRK) family receptor with NaMole level 50% inhibitory concentration.
The proliferation measurement processed by LAROTRECTINIB (LOXO-101) indicates the dose-dependent inhibition of cell proliferation in all three cell lines. For Cuto-3.29, IC50 is less than 100 nm, for KM12 and MO-91, IC50 less than 10 nm, which is consistent with the known efficacy of the TRK kinase family.
| Dasatinib | AZD9291 | Lapatinib ditosylate | Erlotinib Hydrochloride |
| Gefitinib | Niraparib tosylate monohydrate | Imatinib mesylate | Imatinib |
| LOXO 195 | Lapatinib | Ibrutinib | Cabozantinib Malate |
A. Customs clearance
1) By Express:
Normally there is no specical need for the recipient to clear the customs. If the customs has an objection,our rich experienced and peofessional group will help you clear the customs.
2) By Air and by Sea:
Our company will cooperate with the recipient to provide relevant file and information in the customs clearance procedure.
B. Payment
T/T,Wester Union,MoneyGram,****** Trade Assurance,L/C ,Bank transfer etc.
){kind=link}